Recent events
Recent events tied to this brand in public sources.
Back to profile61 entries · Page 2 of 4
2021
RxMx wins healthcare big data award
RxMx, in partnership with Sanofi, won the MedTech Breakthrough Awards' “Best Healthcare Big Data Solution” award for a program and series of technology products.
2021
Cielo and Sanofi renew Asia talent acquisition partnership
Cielo renewed its partnership with Sanofi to provide talent sourcing and recruiting support in Asia. The partnership covers Singapore, Malaysia, Indonesia, Thailand, the Philippines, Hong Kong, Taiwan, Vietnam and Cambodia.
2021
Elsevier releases updated DDIRC 2.0 in PharmaPendium
Elsevier, together with pharmaceutical collaborators, further refined and extended its drug-drug interaction risk calculator in PharmaPendium. The DDIRC 2.0 release includes updated visualizations and filters, a more comprehensive dataset, and improved dossier submission support.
2021
XNK announces joint Phase II study with Karolinska Institutet and Sanofi
XNK Therapeutics announced that it was entering a joint Phase II clinical study with Karolinska Institutet and Sanofi, combining XNK's drug candidate with Sanofi's Sarclisa for patients with multiple myeloma.
2021
Sanofi–SIRION AAV capsid collaboration
SIRION Biotech signed a license and collaboration with Sanofi to develop improved adeno-associated virus capsids for gene therapy treatments for disorders affecting major human organs.
2021
SIRION Biotech and Sanofi sign gene-therapy collaboration
SIRION Biotech announced that it signed a license and collaboration agreement with Sanofi to develop improved tissue-selective AAV vectors for gene therapy treatments.
2021
Novadiscovery raises €2.5 million from Sanofi
Novadiscovery announced that it had raised €2.5 million in a Series A2 financing round from Sanofi. The funds were intended to advance its JINKO clinical-trial simulation platform, support US expansion, and develop a COVID-19 disease model in collaboration with Sanofi.
2021
Sanofi and Neptune Xingchen launch chronic-disease care service
Sanofi and Neptune Xingchen, along with other pharmacy chains, launched the “Health Protection, Love by Your Side” one-stop chronic-disease service in more than ten provinces and cities across China. The service includes home delivery of medicines and end-to-end management.
2021
FDA approves Libtayo for advanced basal cell carcinoma
The U.S. FDA approved Libtayo for patients with advanced basal cell carcinoma previously treated with a hedgehog pathway inhibitor or for whom such treatment is not appropriate; approval was full for locally advanced disease and accelerated for metastatic disease.
2021
Orange, Sanofi, Capgemini and Generali to establish an e-health joint venture
Orange became one of four founding partners of a planned France-based joint venture with Sanofi, Capgemini and Generali, with an initial investment of EUR 24 million shared equally among them. The venture aims to build a digital and open e-health ecosystem.
2021
Sanofi workers strike over planned job cuts
Unions at Sanofi held a one-day strike at a research and development facility in France to protest planned job cuts. Union members said the cuts could slow the fight against the coronavirus pandemic.
2021
Sanofi announces Karl Rotthier as future EUROAPI CEO
Sanofi announced Karl Rotthier's appointment as EUROAPI's future chief executive officer, effective January 18.
2021
Sanofi names its future API company EUROAPI
Sanofi announced EUROAPI as the name of its future European company dedicated to developing, producing and marketing active pharmaceutical ingredients.
2021
Sanofi announces agreement to acquire Kymab
Sanofi announced an agreement to acquire antibody-development company Kymab for $1.1 billion upfront, with up to a further $350 million payable if certain milestones are achieved. The announcement describes a proposed transaction.
2020
Court enters summary judgment in Mylan's favor in Sanofi lawsuit
The U.S. District Court for the District of Kansas entered summary judgment in Mylan's favor in the lawsuit brought by Sanofi over EpiPen products. Viatris characterized the court action as rejecting Sanofi's allegations of anticompetitive practices; the source reports a judgment, not a separate finding of misconduct.
2020
Sanofi renews partnership with WHO
Sanofi signed a renewed partnership agreement with the World Health Organization to fight neglected tropical diseases and eliminate sleeping sickness before 2030; Sanofi committed $25 million in support over five years.
2020
Perrigo completes acquisition of three Eastern European brands
Perrigo announced that it had completed its acquisition from Sanofi of the Emolium, Iwostin and Loxon OTC skincare and hair-loss treatment brands.
2020
Sanofi and MSD agree to test THOR-707 with Keytruda
Sanofi entered an agreement with MSD to collaborate on a phase II trial evaluating Sanofi's investigational candidate THOR-707 alongside MSD's Keytruda.
2020
Sanofi Pasteur India announces Tetraxim launch
Sanofi Pasteur India announced the launch of Tetraxim, a DTaP-IPV booster vaccine for preschoolers. The report says the vaccine protects against diphtheria, pertussis, tetanus, and polio.
2020
Sanofi Philippines launches WeHealth digital ecosystem
Sanofi Philippines launched the WeHealth digital ecosystem, which connects patients with medical professionals and supports consultations, prescribed-medicine purchases and delivery, and patient education.